Related Experiment Video
Updated: Jan 25, 2026

Preparation and In Vitro Characterization of Dendrimer-based Contrast Agents for Magnetic Resonance Imaging
Published on: December 4, 2016
A Novel Magnetic Contrast Agent for Gastrointestinal Mucosa-Targeted Imaging Through Oral Administration
Abstract:
The development of functional contrast agents for diagnosis and therapy of functional gastrointestinal disorders has been a focus of research in recent years. Owing to the excellent distribution and function of 5-HT3 in gastrointestinal mucosa, a novel magnetic contrast agent (AH-CTS-Gd nanosphere) was prepared based on chitosan and 5-HT3 receptors, which realize multifunctional assessment of gastric emptying and gastrointestinal mucosa-targeted MR imaging. The obtained AH-CTS-Gd nanosphere was administered orally to avoid potential toxicity from intravenous administration of a high dose. The results showed that a suitable gastric emptying time and clear gastrointestinal mucosa structure can be observed using the obtained AH-CTS-Gd nanosphere. Immunofluorescence and TEM images of gastrointestinal mucosa suggested a strong combination of the AH-CTS-Gd nanosphere with gastrointestinal mucosa because chitosan and Anti-5-HT3R can combine with gastrointestinal mucosa through electrostatic adherence and antigen-antibody binding. This technology has potential applications in the examination of functional gastrointestinal diseases, without affecting the detection of gastric emptying, possibly enhancing mucosal imaging.
More Related Videos
Related Concept Videos
Oral Hypoglycemic Agents: Glinides
Oral Hypoglycemic Agents: Sulfonylureas
Oral Hypoglycemic Agents: Biguanides and Glitazones
Oral Hypoglycemic Agents: α-Glucosidase Inhibitors
Acarbose and miglitol are...
Magnetic Resonance Imaging
Anatomy of the Gastrointestinal System
Here's a detailed walkthrough of this complex system:

